Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga®) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-Label Study

被引：0
|
作者：
Michael Borte
Isaac R. Melamed
Grazyna Pulka
Barbara Pyringer
Alan P. Knutsen
Hans D. Ochs
Roger H. Kobayashi
Ai Lan Kobayashi
Sudhir Gupta
Magdalena Strach
William Smits
Anna Pituch-Noworolska
James N. Moy
机构：
[1] Klinikum St. Georg gGmbH,Klinik für Kinder
[2] Hospital St. Georg gGmbH Leipzig, und Jugendmedizin
[3] IMMUNOe Research Center Centennial,Immunodeficiency Centre Leipzig (IDCL)
[4] Uniwersytetu Jagiellońskiego,Klinika Alergologii Collegium Medicum
[5] Octapharma Pharmazeutika Produktionsges.m.b.H,Clinical Research and Development Department
[6] Saint Louis University,Department of Pediatrics
[7] University of Washington and Seattle Children’s Research Institute,Division of Pediatric Allergy/Immunology
[8] UCLA School of Medicine,undefined
[9] University of California,undefined
[10] Jagiellonian University Medical College,undefined
[11] The Allergy and Asthma Center,undefined
[12] University Children Hospital,undefined
[13] Stroger Hospital of Cook County,undefined
来源：
Journal of Clinical Immunology | 2017年 / 37卷
关键词：
Primary immunodeficiency diseases; intravenous immunoglobulin; panzyga®; serious bacterial infections;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：603 / 612
页数：9
相关论文
共 50 条
  • [1] Efficacy and Safety of Human Intravenous Immunoglobulin 10% (PanzygaA®) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-Label Study
    Borte, Michael
    Melamed, Isaac R.
    Pulka, Grazyna
    Pyringer, Barbara
    Knutsen, Alan P.
    Ochs, Hans D.
    Kobayashi, Roger H.
    Kobayashi, Ai Lan
    Gupta, Sudhir
    Strach, Magdalena
    Smits, William
    Pituch-Noworolska, Anna
    Moy, James N.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 (06) : 603 - 612
  • [2] Pharmacokinetics of a novel human intravenous immunoglobulin 10% in patients with primary immunodeficiency diseases: Analysis of a phase III, multicentre, prospective, open-label study
    Melamed, Isaac R.
    Borte, Michael
    Trawnicek, Laurenz
    Kobayashi, Ai-Lan
    Kobayashi, Roger H.
    Knutsen, Alan
    Gupta, Sudhir
    Smits, William
    Pituch-Noworolska, Anna
    Strach, Magdalena
    Pulka, Grazyna
    Ochs, Hans D.
    Moy, James N.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 118 : 80 - 86
  • [3] Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia
    Björkander, J
    Nikoskelainen, J
    Leibl, H
    Lanbeck, P
    Wallvik, J
    Lumio, JT
    Braconier, JH
    Pavlova, BG
    Birthistle, K
    Engl, W
    Walter, S
    Ehrlich, HJ
    VOX SANGUINIS, 2006, 90 (04) : 286 - 293
  • [4] Efficacy and Safety of Benvitimod in Patients With Palmoplantar Pustulosis: An Open-Label, Multicenter, Prospective Study
    Wang, Guangping
    Zhang, Shuai
    Yan, Huimin
    Qi, Fang
    Zhang, Bingxin
    Li, Yan
    Wang, Hongmei
    Song, Jingna
    Wang, Siyao
    Zeng, Sanwu
    Ji, Liming
    DERMATOLOGIC THERAPY, 2024, 2024
  • [5] Efficacy of tacrolimus in primary kidney transplant patients: Multicenter, open-label prospective study
    Park, K
    Ahn, C
    Bang, BK
    Kang, CM
    Kim, SI
    Kim, SJ
    Kim, YS
    Kim, YS
    Koh, YB
    Kwak, JY
    Kwon, OJ
    Moon, IS
    Moon, JI
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (07) : 1705 - 1708
  • [6] Intravenous Immunoglobulin Replacement Therapy in the Treatment of Patients with Common Variable Immunodeficiency DiseaseAn Open-Label Prospective Study
    Karolina Kasztalska
    Maciej Ciebiada
    Barbara Cebula-Obrzut
    Pawet Górski
    Clinical Drug Investigation, 2011, 31 : 299 - 307
  • [7] Intravenous Immunoglobulin Replacement Therapy in the Treatment of Patients with Common Variable Immunodeficiency Disease An Open-Label Prospective Study
    Kasztalska, Karolina
    Ciebiada, Maciej
    Cebula-Obrzut, Barbara
    Gorski, Pawel
    CLINICAL DRUG INVESTIGATION, 2011, 31 (05) : 299 - 307
  • [8] Efficacy and Safety of Ustekinumab for Chronic Pouchitis: A Prospective Open-label Multicenter Study
    Outtier, An
    Louis, Edouard
    Dewit, Olivier
    Reenaers, Catherine
    Schops, Ganel
    Lenfant, Matthias
    Pontus, Emilie
    De Hertogh, Gert
    Verstockt, Bram
    Sabino, Joao
    Vermeire, Severine
    Ferrante, Marc
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (12)
  • [9] Efficacy and Safety of Intravenous Immunoglobulin as Adjuvant Treatment for Refractory Neuropathic Pain. Results of an Open-Label, Multicenter Study
    Jann, Stefano
    Francia, Ada
    Fruguglietti, Maria E.
    Franceschini, Luisa De Toni
    Sterzi, Roberto
    PAIN MEDICINE, 2012, 13 (10) : 1334 - 1341
  • [10] Interim Safety Data in a Prospective, Open-label, Multi-center Study of the Efficacy, Safety, Tolerability, and Pharmacokinetics of Plasmacap Ig in Patients with Primary Immunodeficiency Diseases (Pidd)
    Wasserman, Richard L.
    Guindon, Jacinthe
    Seda, Jen
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB117 - AB117
12345